ZURICH, May 21, 2026 /PRNewswire/ -- Chubb Limited (NYSE: CB) announced today that at its 2026 Annual General Meeting, held at the company's offices in Zurich, Switzerland, shareholders approved a 5.
OLDWICK, N.J.--(BUSINESS WIRE)-- #insurance--AM Best has assigned a Long-Term Issue Credit Rating of “a+” (Excellent) to Chubb INA Holdings LLC's (Chubb) (Delaware) recently announced USD 1.0 bill
The competition among card issuers is no longer centered only on rewards rates or promotional offers. Increasingly, it is about whether an issuer can become embedded deeply enough in a customer's dail
ZURICH, May 18, 2026 /PRNewswire/ -- Chubb Limited (NYSE: CB) announced today that its subsidiary, Chubb INA Holdings LLC, has priced a public offering of $1 billion of 5.30% senior notes due 2036 (t
OLDWICK, N.J.--(BUSINESS WIRE)-- #insurance--AM Best has assigned Long-Term Issue Credit Ratings of “a+” (Excellent) to Chubb INA Holdings LLC (Chubb) (Delaware) recently announced CNY 4.0 billion
Recently, Zacks.com users have been paying close attention to Chubb (CB). This makes it worthwhile to examine what the stock has in store.
Chubb Limited is betting big on AI and digital transformation, targeting lower costs, automated processes, and stronger underwriting profitability.
PLMR beat Q1 estimates as revenues jump 58.7% on higher premiums and investment income despite rising expenses and weaker underwriting income.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
/PRNewswire/ -- Verified Clinical Trials (VCT), líder mundial en soluciones de registro de sujetos para ensayos clínicos, y Chubb anunciaron hoy una alianza
UNM Q1 earnings miss estimates as higher benefit costs and weaker international results offset premium growth and strong sales momentum.
/PRNewswire/ -- Verified Clinical Trials (VCT), leader mondial des solutions de registre de sujets d'essais cliniques, et Chubb ont annoncé aujourd'hui une
BOCA RATON, Fla., April 28, 2026 /PRNewswire/ -- Verified Clinical Trials (VCT), the global leader in clinical trial subject registry solutions, and Chubb today announced a strategic alliance focused
Zacks.com users have recently been watching Chubb (CB) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
BRK.B slid below its 50-day SMA, flashing a bearish signal. Valuation looks rich, and sentiment is mixed.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE